Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-28T09:53:35.112Z Has data issue: false hasContentIssue false
  • English
  • Français

Infection Control: The Immunocompromised Host

Published online by Cambridge University Press:  21 June 2016

Lowell S. Young
Lowell S. Young*
Affiliation:
Pacific Presbyterian Medical Center, the Kuzell Institute for Arthritis and Infections Diseases, and the University of California, San Francisco, California
*
2200 Webster St., Suite 305, San Francisco, CA 94115
Get access Rights & Permissions [Opens in a new window]

Extract

I have two major concerns about the immunocompromised host field in 1989. The first relates to the tremendous impact that acquired immunodeficiency syndrome (AIDS) has had on nosocomial infections and the management of hospitalized patients. It is a major consideration in screening patients for organ transplants. Concern about AIDS influences all aspects of blood transfusion therapy.

The second concern relates to the increasing demand for expensive technologically-oriented procedures involved in the management of immunocompromised hosts. I believe the demand for these approaches is irresistible and adds to the mounting problems that hospitals face in containing basic costs. Since there is a finite dollar available for medical expenses, 1 see these demands exacerbating the rationing of medical resources.

Type
Program Summaries
Information
Infection Control & Hospital Epidemiology , Volume 10 , Issue 6 , June 1989 , pp. 274 - 275
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1989

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)